BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31677525)

  • 1. Generation of a WWTR1 mutation induced pluripotent stem cell line, MUSIi012-A-1, using CRISPR/Cas9.
    Lorthongpanich C; Jiamvoraphong N; Supakun P; Damkham N; Terbto P; Waeteekul S; U-Pratya Y; Laowtammathron C; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101634. PubMed ID: 31677525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
    Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a PDX1-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system.
    Lee Y; Choi HY; Kwon A; Park H; Park MH; Kim JW; Kim MJ; Kim YO; Kwak S; Koo SK
    Stem Cell Res; 2019 Dec; 41():101632. PubMed ID: 31683099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of RUNX1c-eGFP induced pluripotent stem cell, MUSIi012-A-4, using CRISPR/Cas9.
    Srisook P; Laowtammathron C; Lorthongpanich C; Klaihmon P; Terbto P; Waeteekul S; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2023 Mar; 67():103035. PubMed ID: 36753833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP-depleted iPSC MUSIi012-A-2 maintained all normal stem cell characteristics.
    Lorthongpanich C; Laowtammathron C; Jiamvoraphong N; Srisook P; Chingsuwanrote P; Klaihmon P; Damkham N; Terbto P; Waeteekul S; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2020 Mar; 43():101723. PubMed ID: 32018207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing.
    Feng H; Li Q; Margolis RL; Li PP
    Stem Cell Res; 2021 May; 53():102346. PubMed ID: 34087983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9.
    Yuan F; Guo D; Liu Y; Xu Y; Gao G; Wu Y; Yang F; Ke X; Lai K; Wei H; Li YX
    Stem Cell Res; 2018 Jan; 26():67-71. PubMed ID: 29247816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing.
    Zhao H; He L; Huang H; Li S; Cheng N; Tang F; Han X; Lin Z; Huang R; Zhou P; Deng S; Huang J; Li Z
    Stem Cell Res; 2020 Oct; 48():102003. PubMed ID: 32977294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
    Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing.
    Lilianty J; Nur Patria Y; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
    Stem Cell Res; 2020 May; 45():101843. PubMed ID: 32446218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing.
    Getachew A; Yang Z; Huang X; Wu F; Liu YY; Yan C; Yang F; Li Y
    Stem Cell Res; 2021 Jul; 54():102401. PubMed ID: 34058685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a homozygous ARHGAP11B knockout hiPSC line by CRISPR/Cas9 system.
    Liu Y; Jin Y; Chen T; Wu Y; Peng X; Li W; Wei S; Chen M; Zou Q; Guo S; Xu J; Tang C; Zhou X
    Stem Cell Res; 2022 May; 61():102764. PubMed ID: 35358830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two compound heterozygous HGSNAT-mutated lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo C syndrome.
    Benetó N; Cozar M; García-Morant M; Creus-Bachiller E; Vilageliu L; Grinberg D; Canals I
    Stem Cell Res; 2019 Dec; 41():101616. PubMed ID: 31731183
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell type-specific YAP1-WWTR1/TAZ transcriptional responses after autophagy perturbations are determined by levels of α-catenins (CTNNA1 and CTNNA3).
    Pavel M; Park SJ; Tanasa R; Rubinsztein DC
    Autophagy; 2021 Jul; 17(7):1788-1790. PubMed ID: 34036899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology.
    Fulgencio-Covián A; Álvarez M; Pepers BA; López-Márquez A; Ugarte M; Pérez B; van Roon-Mom WMC; Desviat LR; Richard E
    Stem Cell Res; 2020 Dec; 49():102055. PubMed ID: 33128956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing.
    Bogomiakova ME; Sekretova EK; Eremeev AV; Shuvalova LD; Bobrovsky PA; Zerkalenkova EA; Lebedeva OS; Lagarkova MA
    Stem Cell Res; 2021 Aug; 55():102451. PubMed ID: 34237591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.
    Kim SH; Basili T; Dopeso H; Da Cruz Paula A; Bi R; Issa Bhaloo S; Pareja F; Li Q; da Silva EM; Zhu Y; Hoang T; Selenica P; Murali R; Chan E; Wu M; Derakhshan F; Maroldi A; Hanlon E; Ferreira CG; Lapa E Silva JR; Abu-Rustum NR; Zamarin D; Chandarlapaty S; Matrai C; Yoon JY; Reis-Filho JS; Park KJ; Weigelt B
    J Pathol; 2022 Aug; 257(5):635-649. PubMed ID: 35411948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a human induced pluripotent stem cell line with Cas9 driven by Tet-on operator via AAVS1 safe harbor gene-editing.
    Ding Y; Wang L; Ji W; Chen Z; Wang D; Chen C; Tong H; Han Z; Niu C; Chu M; Huang J; Guo X
    Stem Cell Res; 2020 Dec; 49():102064. PubMed ID: 33207306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of NERCe003-A-3, a p53 compound heterozygous mutation human embryonic stem cell line, by CRISPR/Cas9 editing.
    Li Y; Huang C; Zha L; Kong M; Yang Q; Zhu Y; Peng Y; Ouyang Q; Lu G; Lin G; Zhou D
    Stem Cell Res; 2019 Jan; 34():101371. PubMed ID: 30658254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.